Back to search results

Mobile App for Cardiovascular Health During Pregnancy

This study is looking at how a mobile exercise app called BumptUp can help pregnant women improve their heart health and feel more motivated to exercise. The app was designed specifically for pregnancy with safety features. Researchers will measure changes in your cardiovascular health, like how well your blood vessels expand (Flow-Mediated Dilation or FMD), after using the app for 8 weeks. You may be able to join if you are a woman between 18 and 45 years old, 20-24 weeks pregnant, generally healthy with a single pregnancy, and currently exercise less than 90 minutes per week. The study aims to enroll 50 participants, but its current status is unclear.

Study design
This is an interventional study involving 50 pregnant women. Participants will use the BumptUp mobile exercise app.
What's involved
You would use the BumptUp mobile exercise app for 8 weeks. Your Flow-Mediated Dilation (FMD) will be measured at the end of this 8-week period.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07166822

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

Recruiting
NAAges 18–45Interventional
Old Dominion University
~50 participants
Updated 2025-09-10 on ClinicalTrials.gov
What's tested:Experimental group using BumptUp mobile exercise app

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Flow mediated dilation
Measured over 8 weeks of intervention period

Conditions

Cardiovascular (CV) Risk
Exercise

Explore related trials

Pregnancy

Where it's being run

1 sites across 1 states
Virginia1

Who to contact

Principal Investigator, PhD
[email protected]
757-683-4974
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age: 18-45 years.
Pregnant women who are 20-24 weeks pregnant at enrollment
Sedentary, as defined by completing less than 90 minutes of exercise each week.
Generally healthy, uncomplicated pregnancies.
Free of physical limitations that may interfere with alterations in daily physical activity levels.
Single gestation.
Have a smartphone
Under the routine medical care of an obstetrician or certified nurse midwife during their current pregnancy.
Women speaking English.

Exclusion

Physician diagnosed cardiovascular/ vascular complications (heart disease, high blood pressure, Raynaud's phenomenon etc.)
Physician diagnosed metabolic diseases (diabetes, hypothyroidism)
Musculoskeletal injuries (broken bones, back pain, ankle sprain, muscle pull, etc.)
Medications that may impact blood vessel function such as hypertension medication (Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Calcium channel blocker, beta blocker), lipid lowering agents (statins), Nitrates, steroids, etc.
Complications associated with pregnancy that would be exacerbated by exercise such as lung disease, persistent spotting/bleeding or Placental Previa, premature labor, ruptured membranes, evidence of intrauterine growth restriction, pregnancy induced hypertension or pre-eclampsia, uncontrolled epileptic fits/seizures.
Smoking within the previous 3 months.

What this trial measures

  • Flow mediated dilation8 weeks of intervention period

    The cardiovascular health via flow mediated dilation (% change from baseline) will be assessed